Bad news for wellness programs: A $550 weight-loss incentive doesn’t do squat
The $550 premium discount may not have been large enough.
The $550 premium discount may not have been large enough.
Maybe Code Black is the new normal?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Plus, the Supreme Court hears a case about healthcare price transparency, primary care docs have new incentives to coordinate care, while investors flock to medical device stocks.
Patient safety advocates affiliated with the National Patient Safety Foundation have proposed instituting a set of "must-do" practices for all healthcare organizations.
Aetna Foundation leaders Dr. Garth Graham, MaryLynn Ostrowski and Alyse Sabina made their case in a post on the Health Affairs blog.
In a blog post for policy journal Health Affairs, national health IT coordinator Dr. Karen DeSalvo spelled out a three-part agenda for realizing the promise of health IT through interoperable, secure health records.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
When it comes to thinking about actually informing cancer patients and understanding healthcare cost effectiveness, monitoring death prevention might be better than looking at survival rates.